Public Speaker



R E S E A R C H  N E W S

UCSC News- UC Santa Cruz Joins the University of California Drug Discovery Consortium

We are happy to announce that UC Santa Cruz has UCDDC. Scott Lokey, professor of chemistry and biochemistry and director of the UCSC Chemical Screening Center, is the UCSC campus lead and a member of the UC DDC executive committee.

Robert Damoiseaux.jpg
Pharmafile - Merck and UCLA Find New COVID-19 Treatment Candidate

Our UCLA campus lead Professor Robert Damoiseaux and his research team discover compounds that could treat COVID-19. This incredible work was published in the journal Cell Reports and highlighted in a Pharmafile article.

Dr. Julia Schaletzky.png
NBC-Where Are The Cures For Covid-19?

Our very own Dr. Julia Schaletzky and her team were highlighted on NBC news. Dr. Schaletzky and her team tested Remdesivir in combination with thousands of approved drugs to see if just one would make Remdesivir better at killing the virus. 

alessandra franco.jpg
Translational Research at UCSD Tackles Inflammatory Disease With Promise of a New Peptide Therapeutic

Professor Alessandra Franco, MD, PhD, of the University of California, San Diego, leads researchers in identifying Fc peptides that promote adaptive immune regulation and provide a novel alternative to current autoimmune disease therapeutics.  

UCD Researchers Create Cell-Free Regenerative Therapy Utilizing UC DDC Seed Grant Award

Early research originating from the laboratory of Johnathon Anderson, PhD, at the University of California, Davis, Medical Center shows the promise of utilizing exosomes as a new therapeutic platform to treat neurological and cardiovascular diseases.

UCSF Researchers Design Novel Pin-1 Inhibitor as a Result of UC DDC Seed Grant Award

Towards the mission of fighting cancer through drug discovery, Jason Gestwicki, PhD, at the University of California, San Francisco, has led his team to discover a first-in-class Pin1 inhibitor.

Test Tubes
Test Tubes